| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | JD COM INC ADR | 96,968,061 | 2,466,867,000 | 55.04% | ||
| 2 | MONDELEZ INTL INC | 8,899,096 | 394,497,000 | 8.80% | ||
| 3 | ENSTAR GROUP LIMITED COM | 1,750,218 | 346,018,000 | 7.72% | ||
| 4 | PRICELINE GRP INC | 187,490 | 274,872,000 | 6.13% | ||
| 5 | BAIDU INC | 1,233,120 | 202,737,000 | 4.52% | ||
| 6 | 58 COM INC | 5,550,451 | 155,413,000 | 3.47% | ||
| 7 | MELCO ENTMT ADR | 7,307,515 | 116,189,000 | 2.59% | ||
| 8 | SINA CORP | 1,420,208 | 86,334,000 | 1.93% | ||
| 9 | CTRIP COM INTL LTD | 1,967,994 | 78,720,000 | 1.76% | ||
| 10 | Sohu.com Inc | 1,650,727 | 55,943,000 | 1.25% | ||
| 11 | TAL EDUCATION GROUP | 598,920 | 42,014,000 | 0.94% | ||
| 12 | BEIGENE LTD | 1,364,820 | 41,436,000 | 0.92% | ||
| 13 | MOMO INC | 2,069,465 | 38,037,000 | 0.85% | ||
| 14 | WebMD Health Corp | 554,717 | 27,497,000 | 0.61% | ||
| 15 | FIBROGEN INC COM | 1,000,000 | 21,400,000 | 0.48% | ||
| 16 | INTRA CELLULAR THERAPIES INC COM | 1,000,000 | 15,090,000 | 0.34% | ||
| 17 | BLUEPRINT MEDICINES CORP COM | 482,455 | 13,533,000 | 0.30% | ||
| 18 | ACCELERON PHARMA | 500,000 | 12,760,000 | 0.28% | ||
| 19 | ZTO EXPRESS CAYMAN INC | 1,000,462 | 12,076,000 | 0.27% | ||
| 20 | LINE CORP | 336,800 | 11,455,000 | 0.26% | ||
| 21 | CAMECO CORP | 1,025,700 | 10,739,000 | 0.24% | ||
| 22 | PROTEOSTASIS THERAPEUTICS IN | 865,923 | 10,616,000 | 0.24% | ||
| 23 | Theravance Biopharma Inc | 304,256 | 9,700,000 | 0.22% | ||
| 24 | AC Immune SA | 550,000 | 7,139,000 | 0.16% | ||
| 25 | TIGENIX | 483,870 | 7,055,000 | 0.16% | ||
| 26 | Clearside Biomedical Inc | 600,000 | 5,364,000 | 0.12% | ||
| 27 | FANG HLDGS LIMITED ADR | 1,500,000 | 4,920,000 | 0.11% | ||
| 28 | Nabriva Therapeutics AG | 700,000 | 4,165,000 | 0.09% | ||
| 29 | PROTHENA CORP PLC | 75,000 | 3,689,000 | 0.08% | ||
| 30 | PAYPAL HLDGS INC | 75,186 | 2,968,000 | 0.07% | ||
| 31 | XUNLEI LTD SPONSORED ADR | 403,041 | 1,556,000 | 0.03% | ||
| 32 | ALIBABA GROUP HLDG LTD | 9,262 | 813,000 | 0.02% | ||
| 33 | LENDINGCLUB CORP | 100,000 | 525,000 | 0.01% | ||
| 34 | SERES THERAPEUTICS INC | 21,093 | 209,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000902664-17-001220, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
